Skip to content
10-Q

Quarterly Report

Edgewise Therapeutics, Inc. EWTX

0001104659-25-107427

← back to feed
Filed
Nov 6, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 31, 2025 105.87M sh
Shares Diluted Q3 2025 · Sep 30, 2025 105.49M sh
Shares Diluted Q3 2025 · Sep 30, 2025 101.89M sh
Shares Diluted Q3 2025 · Sep 30, 2024 93.81M sh
Shares Diluted Q3 2025 · Sep 30, 2024 91.64M sh
Capex Q3 2025 · Sep 30, 2025 $183K
Capex Q3 2025 · Sep 30, 2024 $1.04M
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$105.22M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$82.07M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $46M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $41.67M
Stockholders Equity Q3 2025 · Sep 30, 2025 $558.65M
Stockholders Equity Q3 2025 · Jun 30, 2025 $589.07M
Stockholders Equity Q3 2025 · Mar 31, 2025 $429.72M
Stockholders Equity Q3 2025 · Dec 31, 2024 $459.22M
Stockholders Equity Q3 2025 · Sep 30, 2024 $488.88M
Stockholders Equity Q3 2025 · Jun 30, 2024 $510.47M
Stockholders Equity Q3 2025 · Mar 31, 2024 $534.94M
Stockholders Equity Q3 2025 · Dec 31, 2023 $318.83M
Current Liabilities Q3 2025 · Sep 30, 2025 $21.65M
Current Liabilities Q3 2025 · Dec 31, 2024 $23.86M
Total Liabilities Q3 2025 · Sep 30, 2025 $24.82M
Total Liabilities Q3 2025 · Dec 31, 2024 $27.6M
Current Assets Q3 2025 · Sep 30, 2025 $573.9M
Current Assets Q3 2025 · Dec 31, 2024 $475.48M
Total Assets Q3 2025 · Sep 30, 2025 $583.47M
Total Assets Q3 2025 · Dec 31, 2024 $486.82M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.39
Eps Diluted Q3 2025 · Sep 30, 2025 −$1.15
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.36
Eps Diluted Q3 2025 · Sep 30, 2024 −$1.03
Eps Basic Q3 2025 · Sep 30, 2025 −$0.39
Eps Basic Q3 2025 · Sep 30, 2025 −$1.15
Eps Basic Q3 2025 · Sep 30, 2024 −$0.36
Eps Basic Q3 2025 · Sep 30, 2024 −$1.03
Sga Expense Q3 2025 · Sep 30, 2025 $9.38M
Sga Expense Q3 2025 · Sep 30, 2025 $27.63M
Sga Expense Q3 2025 · Sep 30, 2024 $8.21M
Sga Expense Q3 2025 · Sep 30, 2024 $22.7M
Rd Expense Q3 2025 · Sep 30, 2025 $37.48M
Rd Expense Q3 2025 · Sep 30, 2025 $107.8M
Rd Expense Q3 2025 · Sep 30, 2024 $32.22M
Rd Expense Q3 2025 · Sep 30, 2024 $90.6M
Net Income Q3 2025 · Sep 30, 2025 −$40.67M
Net Income Q3 2025 · Sep 30, 2025 −$117.58M
Net Income Q3 2025 · Jun 30, 2025 −$36.12M
Net Income Q3 2025 · Mar 31, 2025 −$40.8M
Net Income Q3 2025 · Sep 30, 2024 −$34.13M
Net Income Q3 2025 · Sep 30, 2024 −$94.15M
Net Income Q3 2025 · Jun 30, 2024 −$31.5M
Net Income Q3 2025 · Mar 31, 2024 −$28.53M
Operating Income Q3 2025 · Sep 30, 2025 −$46.86M
Operating Income Q3 2025 · Sep 30, 2025 −$135.43M
Operating Income Q3 2025 · Sep 30, 2024 −$40.43M
Operating Income Q3 2025 · Sep 30, 2024 −$113.29M
Stock Issued Q3 2025 · Apr 3, 2025 9.94M sh
Stock Issued Q3 2025 · Jan 23, 2024 21.82M sh